Metropolitan Life Insurance Company (MetLife)’s Cogent Biosciences COGT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-3,461
| Closed | -$23.3K | – | 475 |
|
|
2024
Q1 | $23.3K | Buy |
3,461
+161
| +5% | +$1.08K | ﹤0.01% | 1785 |
|
|
2023
Q4 | $19.4K | Sell |
3,300
-1,430
| -30% | -$8.41K | ﹤0.01% | 1935 |
|
|
2023
Q3 | $46.1K | Buy |
4,730
+1,172
| +33% | +$11.4K | ﹤0.01% | 1447 |
|
|
2023
Q2 | $42.1K | Buy |
+3,558
| New | +$42.1K | ﹤0.01% | 1522 |
|
|
2023
Q1 | – | Sell |
-3,857
| Closed | -$44.6K | – | 2341 |
|
|
2022
Q4 | $44.6K | Hold |
3,857
| – | – | ﹤0.01% | 1547 |
|
|
2022
Q3 | $57.5K | Buy |
3,857
+1,218
| +46% | +$18.2K | ﹤0.01% | 1359 |
|
|
2022
Q2 | $23.8K | Hold |
2,639
| – | – | ﹤0.01% | 1959 |
|
|
2022
Q1 | $19.8K | Sell |
2,639
-8,012
| -75% | -$60K | ﹤0.01% | 2105 |
|
|
2021
Q4 | $91.4K | Buy |
10,651
+42
| +0.4% | +$360 | ﹤0.01% | 2533 |
|
|
2021
Q3 | $89.2K | Buy |
+10,609
| New | +$89.2K | ﹤0.01% | 2589 |
|